aethlon_8k-062211.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 22, 2011
AETHLON MEDICAL, INC.
(Exact name of registrant as specified in its charter)
|
Nevada
(State or other jurisdiction of incorporation)
|
000-21846
(Commission File Number)
|
13-3632859
(I.R.S. Employer Identification No.)
|
|
8910 University Center Lane, Suite 660
San Diego, California
(Address of principal executive offices)
|
|
92122
(Zip Code)
|
Registrant’s telephone number, including area code: (858) 459-7800
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01Regulation FD Disclosure
The Registrant disclosed that on Wednesday, June 22, 2011, it made a presentation at the RedChip Small-Cap Equities Virtual Conference VIII. A copy of the presentation materials was made available on the Registrant’s website (www.aethlonmedical.com) under the Events and Presentation section of the Investor Relations page today, June 22, 2011.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
AETHLON MEDICAL, INC.
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date: June 22, 2011
|
By:
|
/s/ James B. Frakes
|
|
|
|
James B. Frakes
|
|
|
|
Chief Financial Officer
|